Back to dashboard
MedicaidCoverageMedium impact

2023.53 Provider Bulletin - Policy Updates and Changes to Clinical Review Criteria pdf

Connecticut Medicaid (HUSKY Health)·CT · Orthopedics, Endocrinology, Neurology +4 more·Provider Bulletin
Effective date
Aug 1, 2023
We identified it
Jun 20, 2026
Days to comply

Summary

Connecticut Medicaid (CMAP) has updated clinical review criteria for multiple services including DME rent-to-purchase programs, specialty drugs like Oxlumo and Tepezza, and orthopedic procedures like MACI. Several policies have been retired and will now use InterQual criteria instead.

Action Required

Action needed
Immediately: Billing team must review updated prior authorization requirements for compression garments (A6549/A4465), specialty drugs (Oxlumo, Tepezza, Spinraza), and MACI procedures for Connecticut Medicaid patients. Access updated policies at https://portal.ct.gov/husky under Medical Management. Contact CHNCT at 1-800-440-5071 for prior authorization questions. Claims may be denied if new criteria are not followed.

Affected Billing Codes

A6549
A4465